UNIVERSITETSSYKEHUSET NORD-NORGE HF

Operating

Forside - Universitetssykehuset Nord-Norge HF

Med pasienten – for pasienten

Yte gode og likeverdige spesialisthelsetjenester til alle som trenger det uavhengig av alder, kjønn, bosted, økonomi og etnisk bakgrunn samt legge til rette for forsking og undervisning på høyt nasjonalt og internasjonalt nivå tilpasset helseforetakets rolle som universitetsklinikk.

Sykehus

Keywords

adult psychiatricmental health careadultschild and youth psychiatrychildrenyoung people

Organization

CEO: DJ
David Johansen1979
Chairman of the board: AM
Anders Mohn Frafjord1972
Years since formation: 24 years; since Dec 21, 2001
Type: Other business enterprise in accordance with special legislation
VAT registered: Yes
Number of employees: 9582

Financials

Total operating income 2024: 10,388,314,000; NOK
Annual total result 2024: -73,927,000; NOK
Total equity 2024: 4,958,354,000; NOK

Last update: Oct 15, 2025

Management

Management / administration

Name	Role	Shares
DJ David Johansen 1979	Managing Director/CEO	-

Board

Name	Role	Shares
BE Beate Ellen Mariann Rahka-Knutsen 1967	Board Member	-
JE Jan Eivind Pettersen 1964	Board Member	-
MF Monica Fyhn Sørensen 1976	Board Member	-
EK Eirik Kjus Aahlin 1980	Board Member	-
RM Rune Moe 1966	Alternate Member	-
GS Gunbjørg Svineng 1968	Deputy Chair	-
AM Anders Mohn Frafjord 1972	Chairman	-
RA Rigmor Abel 1961	Board Member	-
RE Rolf Eigil Bygdnes 1956	Board Member	-
TA Toril Anita Nagelhus Hernes 1967	Board Member	-
VB Vidar Bjørnås 1976	Board Member	-
ØB Øyvind Bakke 1978	Board Member	-
HS Hanne Sofie Yttervik 1966	Alternate Member	-
GM Geir Magne Johnsen 1974	Alternate Member	-
LA Lisa-Mari Andreassen 1978	Board Member	-
JL Jeanett Lund Strand 1983	Alternate Member	-
KO Karina Olsen 1963	Alternate Member	-
KA Kyrre Arne Johansen 1965	Alternate Member	-
H HELSE NORD RHF	Health Enterprise	-

Others

Name	Role	Shares
B BDO AS	Auditor	-

Last update: May 26, 2025

Ownership

Shares owned by the UNIVERSITETSSYKEHUSET NORD-NORGE HF

Name	Share class	Total number of shares	Share
P PROPHYLIX PHARMA HOLDING AS	A-shares	30,001	4.93 %
N NORINNOVA AS	Ordinary shares	364	2.18 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	10,388,314,000	9,443,080,000	9,307,600,102	8,637,559,884
Annual Total Result	-73,927,000	-140,789,000	180,949,274	-89,329,353
Total assets	10,320,124,000	9,833,830,000	9,349,068,864	7,917,875,839
Total liabilities	5,361,770,000	4,801,549,000	4,175,999,598	3,600,755,848
Total equity	4,958,354,000	5,032,281,000	5,173,069,266	4,317,119,992

P&L

Year	2024	2023	2022	2021
Total operating income	10,388,314,000	9,443,080,000	9,307,600,102	8,637,559,884
Total operating costs	10,434,935,000	9,581,559,000	9,116,392,745	8,716,075,585
Operating result	-46,621,000	-138,479,000	191,207,357	-78,515,701
Financial income/costs	-27,306,000	-2,310,000	-10,258,083	-10,813,652
Profit before tax	-73,927,000	-140,789,000	180,949,274	-89,329,353
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-73,927,000	-140,789,000	180,949,274	-89,329,353

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	9,038,520,000	8,785,166,000	7,919,285,912	7,123,116,549
Total current assets	1,281,604,000	1,048,664,000	1,429,782,952	794,759,290
Total assets	10,320,124,000	9,833,830,000	9,349,068,864	7,917,875,839
Short term debt	2,052,512,000	1,948,130,000	1,819,833,116	1,768,450,318
Long term debt	3,309,258,000	2,853,419,000	2,356,166,482	1,832,305,530
Total liabilities	5,361,770,000	4,801,549,000	4,175,999,598	3,600,755,848
Contributed capital	5,206,354,000	5,206,354,000	5,206,353,844	4,531,353,844
Retained earnings	-248,000,000	-174,073,000	-33,284,578	-214,233,852
Total equity	4,958,354,000	5,032,281,000	5,173,069,266	4,317,119,992
Total equity and liabilities	10,320,124,000	9,833,830,000	9,349,068,864	7,917,875,840

Classification

21st company classification

BETA

Industrial large enterprise

UNIVERSITETSSYKEHUSET NORD-NORGE HF983 974 899